Safety and Efficacy Study of Trabectedin for the Treatment of Localized Myxoid / Round Cell Liposarcoma
Clinical trial NCT00579501 · COMPLETED
Trial details
- NCT number
- NCT00579501
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Primary completion
- 2010-01-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.